Is Adagio Medical Holdings, Inc. (ADGM) a Buy, Sell, or Hold?
NASDAQ : ADGM
Adagio Medical Holdings, Inc.
$0.7442 USD
$0.06 (8.88%)
- Volume
- 1.43M
- Average Volume
- 90.87K
- Market Capitalization
- $16.53M
- P/E Ratio
- -0.52
- Dividend Yield
- 0.00%
- Price Target
- $3.00
- Year High
- $2.58
- Year Low
- $0.36
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.41
Company Overview
NASDAQ
Todd Usen
Medical - Devices
Healthcare
ADGM
41
US
USD
Liquidity Metrics
-62.65
1.41
1.15
1.02
0.00
Sales & Valuation
-$
0.00
-39.83
-1.02
-0.73
Profitability
-$1.51
-$25.08M
0.00%
0.00%
-661.85%
-80.08%
P/E Metrics
-0.52
-0.01
-0.01
Analyst Price Target & Rating
$3.00
$3.00
$3.00
1/5
0 Analysts
-75.19%
Financial Health Scores
-4.95
1/9
$7.28M
$39.31M
$33.58M
-$21.34M
Key Metrics (TTM)
$26.36M
0.00
-1.29
1.85
-382.50%
-63.33%
-160.50%
-102.73%
328 days
Company Executives
| Name | Title |
|---|---|
| Antwan Gipson | Senior Vice President of Manufacturing & Operations |
| Deborah Kaster | Chief Financial Officer & Chief Business Officer |
| Maryline Cullen | VP & Corporate Controller |
| Alex Babkin | Chief Technical Officer |
| Ilya Grigorov | Vice President of Global Marketing & Product Management |
| Marie-Claude Jacques | Senior Vice President of Global Sales |
| Nabil Jubran | Chief Compliance Officer |
| Todd Usen | Chief Executive Officer & Director |
Poll Results
No votes yet today — be the first to share your view!
About Adagio Medical Holdings, Inc. (NASDAQ:ADGM) Stock
Adagio Medical Holdings, Inc. is an emerging medical device firm focused on pioneering and commercializing innovative ablation technologies. Its core mission is to provide therapeutic solutions for various cardiac rhythm disorders, including but not limited to atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's current product portfolio showcases advanced offerings such as the iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and its complementary accessories, the vCLAS ventricular ULTC catheter, and the Cryopulse atrial pulsed-field cryoablation catheter, also available with associated accessories. This entity, which commenced operations in 2011, has its principal office situated in Laguna Hills, California. ...
Adagio Medical Reports Second Quarter 2026 Results
2026-08-11 08:30:00
LAGUNA HILLS, Calif.--(BUSINESS WIRE)---- $ADGM #ARRHYTHMIA--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the second quarter ended June 30, 2026. Recent Business Highlights: Announced the successful treatment at the Hospital of University of Pennsylvania of the first patient with the Company's next-generation vCLAS™ Ultra Ultra-Low temperature ablation cat.
Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System
2026-08-03 08:30:00
LAGUNA HILLS, Calif.--(BUSINESS WIRE)---- $ADGM #ARRHYTHMIA--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the successful treatment of the first patient with its next-generation vCLAS Ultra Ultra-Low Temperature Ablation (“ULTA”) system under Expanded Access authorization from the U.S. Food and Drug Administration (“FDA”).The patient, who presented with non-ischemic cardiomyopath.
Robo.ai Announces Core Executive Appointments, Forming a Local UAE Leadership Team at Neurovia AI
2026-07-14 02:00:00
Robo.ai Announces Core Executive Appointments, Forming a Local UAE Leadership Team at Neurovia AI PR Newswire AB
2026-05-21 08:00:00
LAGUNA HILLS, Calif.--(BUSINESS WIRE)---- $ADGM #ARRHYTHMIA--Adagio Medical Holdings, Inc (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the submission of its Premarket Approval (“PMA”) application to the U.S. Food and Drug Administration (“FDA”) for the vCLAS Ventricular Ablation System for the treatment of drug-refractory, recurrent, sustained monomorphic ventricular tachycardia (“VT”) in patients with isch.
Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress
2026-05-12 08:05:00
LAGUNA HILLS, Calif.--(BUSINESS WIRE)---- $ADGM #ARRHYTHMIA--Adagio Medical Holdings, Inc (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the first quarter ended March 31, 2026. Recent Business Highlights: Pivotal results from the FULCRUM-VT trial presented in late-breaking session at Heart Rhythm Society 2026 – the first large-scale, rigorously executed pivotal trial in patients with bot.
Frequently Asked Questions
-
What is the current Adagio Medical Holdings, Inc. (ADGM) stock price?
-
Adagio Medical Holdings, Inc.(NASDAQ:ADGM) stock price is $0.7442 in the last trading session. During the trading session, ADGM stock reached the peak price of $2.582 while $0.363 was the lowest point it dropped to. The percentage change in ADGM stock occurred in the recent session was 8.88% while the dollar amount for the price change in ADGM stock was $0.06.
-
ADGM's industry and sector of operation?
-
The NASDAQ listed ADGM is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of ADGM?
-
Antwan Gipson | Senior Vice President of Manufacturing & Operations
Deborah Kaster | Chief Financial Officer & Chief Business Officer
Maryline Cullen | VP & Corporate Controller
Alex Babkin | Chief Technical Officer
Ilya Grigorov | Vice President of Global Marketing & Product Management -
How many employees does ADGM have?
-
Number of ADGM employees currently stands at 41. ADGM operates from 26051 Merit Circle, Laguna Hills, CA 92653, US.
-
Link for ADGM official website?
-
Official Website of ADGM is: https://adagiomedical.com
-
How do I contact ADGM?
-
ADGM could be contacted at phone #949-348-1188 and can also be accessed through its website. ADGM operates from 26051 Merit Circle, Laguna Hills, CA 92653, US.
-
How many shares of ADGM are traded daily?
-
The average number of ADGM shares traded daily for last 3 months was 90.87K.
-
What is the market cap of ADGM currently?
-
The market value of ADGM currently stands at $16.53M with its latest stock price at $0.7442